Search

everythinglearnresearchcommunity

for

Search:↓

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

A woman's unique dementia was misdiagnosed, a genetic mutation increases Parkinson's risk with age, and finasteride may help with Tourette syndrome.

Men with male pattern baldness have a higher chance of heart disease, especially if they're younger or have severe baldness; no link was found with another type of baldness called alopecia areata.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Skin and hair renewal is maintained by both fast and slow cycling stem cells, with hair regrowth primarily driven by specific stem cells in the hair follicle bulge. These cells can also help heal wounds and potentially treat hair loss.

A gene called APCDD1, which controls hair growth, is found to be faulty in a type of hair loss called hereditary hypotrichosis simplex.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

PLD is an effective and safer alternative for treating breast cancer.

Lampreys have a functional vitamin D receptor that may help detoxify harmful substances.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Mammals might fail to regenerate not because they lack the right cells, but because of how cells respond to their surroundings, and changing this environment could enhance regeneration.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Some systemic treatments work for nail psoriasis but can have serious side effects.

PRP treatment helps hair growth in most cases, but more research needed.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Intermediate hair follicles are a better model for studying hair growth and testing hair loss treatments.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Taking L-tryptophan supplements might cause a condition similar to scleroderma in some people, which can get better after stopping the supplement and starting corticosteroid therapy.

Non-immune factors play a significant role in alopecia areata.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.